Literature DB >> 2650913

Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats.

P W Whitworth1, H M Cryer, R N Garrison, T E Baumgarten, P D Harris.   

Abstract

In order to determine the intestinal microvascular responses to normotensive, high cardiac output (CO) bacteremia, we measured vascular diameters and blood flow at different levels of the intestinal microcirculation during live E. coli bacteremia in male Sprague-Dawley rats (n = 16). Precollicular brainstem transection was used to allow study free of drug anesthesia. The microcirculation of a loop of small intestine (with intact neurovascular connections) was observed by in vivo video microscopy and optical Doppler velocimetry at a magnification of x1,500. Intraluminal microvessel diameters and red cell velocity were measured in successive branches until the vessel entered a villus. CO was measured by transpulmonary thermodilution. Intravenous infusion of 1 x 10(9) live E. coli caused a 20% increase in CO at 50 min and a 14% decrease in systemic vascular resistance. However, microvascular blood flow to the small intestine decreased by 27% at 1 hr and by 56% at 2 hr. Progressive arteriolar constriction (25-50%, P less than .05) occurred at all levels of the intestinal microcirculation. These data indicate that intestinal hypoperfusion caused by arteriolar constriction occurs during high CO bacteremia. This hypoperfusion could contribute to mucosal injury and intestinal mucosal barrier dysfunction during sepsis.

Entities:  

Mesh:

Year:  1989        PMID: 2650913

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  13 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Double-illumination photoacoustic microscopy.

Authors:  Junjie Yao; Konstantin I Maslov; Ernest R Puckett; Kathryn J Rowland; Brad W Warner; Lihong V Wang
Journal:  Opt Lett       Date:  2012-02-15       Impact factor: 3.776

3.  Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat.

Authors:  K Klemm; F G Moody
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

4.  Leucocyte sequestration in endotoxemia and the effect of low-molecular-weight dextran.

Authors:  J T Christenson; A Owunwanne
Journal:  Eur J Nucl Med       Date:  1990

5.  Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.

Authors:  T M McKenna
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study.

Authors:  D F Zandstra; C P Stoutenbeek
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

7.  A prospective randomized trial of enteral glutamine in critical illness.

Authors:  John C Hall; Geoffrey Dobb; Jane Hall; Ruth de Sousa; Lisa Brennan; Rosalie McCauley
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

8.  Intermittent flow increases endotoxin-induced adhesion of human erythrocytes to vascular endothelial cells.

Authors:  Otto Eichelbrönner; William J Sibbald; Ian H Chin-Yee
Journal:  Intensive Care Med       Date:  2003-03-11       Impact factor: 17.440

9.  Microvascular changes explain the "two-hit" theory of multiple organ failure.

Authors:  R N Garrison; D A Spain; M A Wilson; P A Keelen; P D Harris
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Small volume of hypertonic saline as the initial fluid replacement in experimental hypodynamic sepsis.

Authors:  Alejandra del Pilar Gallardo Garrido; Ruy Jorge Cruz; Luiz Francisco Poli de Figueiredo; Maurício Rocha e Silva
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.